Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma
Status:
Withdrawn
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies isolated limb perfusion with melphalan in treating patients
with stage IIIB-IV melanoma or sarcoma. Drugs used in chemotherapy, such as melphalan, work
in different ways to stop the growth of tumor cells, either by killing the cells or by
stopping them from dividing. Heating a chemotherapy solution and infusing it directly into
the arteries around the tumor may kill more tumor cells.
Phase:
N/A
Details
Lead Sponsor:
Albert Einstein College of Medicine Albert Einstein College of Medicine of Yeshiva University